A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines
Crossref DOI link: https://doi.org/10.1007/s11523-015-0364-y
Published Online: 2015-04-29
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shi, Yi
Sun, Lin
Chen, Ge
Zheng, Dongyan
Li, Li
Wei, Wanguo
Text and Data Mining valid from 2015-04-29